|
|
Article: Which Agents are Driving the Growth of the Anemia Market in the United States, Europe, and Japan.
- Article from:
- Business Wire
- Article date:
- March 15, 2007
CopyrightCOPYRIGHT 2007 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c52196) has announced the addition of the Decision Resources, Inc report: The Anemia Market: Biogenerics and Second-Generation Products Drive Change to their offering.
The availability of recombinant biologic agents has revolutionized the treatment of anemia and has created a market with a small number of players. However, the inconvenient administration and high prices of these biologic agents represent an opportunity for companies to enter this market with improved alternatives.
Get the Answers You Need to Shape Your Strategy
Worldwide sales of ...